Serotonin as a modulator of immune function: An overview

Current Immunology Reviews

Volumn 2, Issue 1, 2006, Pages 27-35

  Cloëz Tayarani, Isabelle ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

5 HT receptors; Blood cells; Immunoregulation; Lymphocyte proliferation; MAP kinase; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOKINE; FENFLURAMINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; B LYMPHOCYTE ACTIVATION; CELL ACTIVITY; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPRESSION; DRUG MECHANISM; DRUG TARGETING; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; INFLAMMATORY CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NEUROIMMUNOLOGY; NEUROMODULATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TARGET CELL;

EID: 33745915246     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339506775471893     Document Type: Review

References (101)

1. Douglas WW. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Goodman and Gillman Ed, The pharmacological basis of therapeutics. 6th edition. New York, Mc Millan, 1980; 609-46.
2. Walker RF, Codd EE. Neuroimmunomodulatory interactions of norepinephrine and serotonin. J Neuroimmunol 1985; 10: 41-58.
3. Tranzer JP, Da Prada M, Pletscher A. Storage of 5-Hydroxytryptamine in megakaryocytes. J Cell Biol 1972; 52: 191-7.
4. Mossner R, Lesch KP. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 1998; 12249-71.
5. Benedict CR, Mathew B, Rex KA, Cartwright J Jr, Sordahl LA. Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation. Circ Res 1986; 58: 58-67.
6. Timmons S, Huzoor-Akbar, Grabarek J, Kloczewiak M, Hawiger J. Mechanism of human platelet activation by endotoxic glycolipid-bearing mutant Re595 of Salmonella minnesota. Blood 1986; 68: 1015-23.
7. Tamir H, Payette RF, Huang YL, Liu KP, Gershon MD. Human serotonectin: a blood glycoprotein that binds serotonin and is associated with platelets and white blood cells. J Cell Sci 1985; 73: 187-206.
8. Parrat JR, West GB. 5-hydroxytryptamine and tissue mast cells. J Physiol 1957; 137: 169-78.
9. Williams JM, Felten DL. Sympathetic innervation of murine thymus and spleen: a comparative histofluorescence study. Anat Rec 1981; 199: 531-42.
10. Hori T, Katafuchi T, Take S, Shimizu N, Niijima A. The autonomic nervous system as a communication channel between the brain and the immune system. Neuroimmunomodulation 1995; 2: 203-15.
11. Kawashima K, Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 2003; 26: 675-96.
12. Ader R, Cohen N, Felden D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995; 345: 99-103.
13. Bellinger DL, Felten SY, Felten DL. Maintenance of noradrenergic sympathetic innervation in the involuted thymus of the aged Fischer 344 rat. Brain Behav Immun 1988; 2: 133-50.
14. Fuchs BA, Campbell KS, Munson AE. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell Immunol 1988; 117: 339-51.
15. Ader R, Felten D, Cohen N. Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol 1990; 30: 561-602.
16. Felten SY, Olschowka J. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp. J Neurosci Res 1987; 18: 37-48.
17. Weihe E, Nohr D, Michel S, et al. Molecular anatomy of the neuroimmune connection Int J Neurosci 1991; 59: 1-23.
18. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
19. Vizi ES, Elenkov IJ. Nonsynaptic noradrenaline release in neuroimmune responses. Acta Biol Hung 2002; 53: 229-44.
20. Zifa E, Fillion G. 5-Hydroxytryptamine receptors. Pharmacol Rev 1992; 44: 401-58.
21. Madden KS, Felten SY, Felten DL, Hardy CA, Livnat S. Sympathetic nervous system modulation of the immune system. II. Induction of lymphocyte proliferation and migration in vivo by chemical sympathectomy. J Neuroimmmunol 1994; 49: 1-275.
22. Jackson JC, Walker RF, Brooks WH, Roszman TL. Specific uptake of serotonin by murine macrophages. Life Sci 1988; 42: 1641-50.
23. Finocchiaro LM, Arzt ES, Fernandez-Castelo S, Criscuolo M, Finkielman S, Nahmod VE. Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway. J Interferon Res 1988; 8: 705-16.
24. Arzt ES, Fernandez-Castelo S, Finocchiaro LM, et al. Immunomodulation by indoleamines: serotonin and melatonin action on DNA and interferon-gamma synthesis by human peripheral blood mononuclear cells. J Clin Immunol 1988; 8: 513-20.
25. Gordon J, Barnes NM. Lymphocytes transport serotonin and dopamine: agony or ecstasy? Trends Immunol 2003; 24: 438-43.
26. Marazziti D, Rossi A, Giannaccini G, Baroni S, Lucacchini A, Cassano GB. Presence and characterization of the serotonin transporter in human resting lymphocytes. Neuropsychopharmacology 1998; 19: 154-59.
27. Barkan T, Gurwitz D, Levy G, Weizman A, Rehavi M. Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes. Eur Neuropsychopharmacol 2004; 14: 237-43.
28. Pellegrino TC, Bayer BM. Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release. Neuroimmunomodulation 2000; 8: 179-87.
29. Ferriere F, Khan NA, Meyniel JP, Deschaux P. Characterisation of serotonin transport mechanisms in rainbow trout peripheral blood lymphocytes: role in PHA-induced lymphoproliferation. Dev Comp Immunol 1999; 23: 37-50.
30. Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003; 4: 1002-12.
31. Ramamoorthy S, Ramamoorthy JD, Prasad PD, et al. Regulation of the human serotonin transporter by interleukin-1 beta. Biochem Biophys Res Comm 1995; 216: 560-67.
32. Mossner R, Heils A, Stober G, Okladnova O, Daniel S, Lesch KP. Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem Int. 1998; 33: 251-4.
33. Mössner R, Daniel S, Schmitt A, Albert D, Lesch KP. Modulation of serotonin transporter function by interleukin-4. Life Sci 2001; 68: 874-80.
34. Serafeim A, Grafton G, Chamba A, et al. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood 2002; 99: 2545-53.
35. Hoyer D, Clarke DE, Fozard JR, et al. VII. International Union of Pharmacology Classification of receptors for 5-Hydroxytryptamine (serotonin). Pharmacol Rev 1994; 46: 157-203.
36. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002; 71: 533-54.
37. 2-receptors and serotonin release: their role in human platelet aggregation. Life Sci 1993; 53: 209-15.
38. 2 receptor. Blood Coagul Fibrinolysis 1996; 7: 127-33.
39. Vetoshkin AV, Fomenko AM, Zozulia AA. Lymphocyte serotonin receptors: a radioreceptor study. Biull Eksp Biol Med 1982; 94: 52-3.
40. Bonnet M, Lespinats G, Burtin C. Evidence for serotonin (5HT) binding sites on murine lymphocytes. Int J Immunopharmacol 1987; 9: 551-58.
41. Choquet D, Korn H. Dual effects of serotonin on a voltage-gated conductance in lymphocytes. Proc Natl Acad Sci USA 1988; 85: 4557-61.
42. Aune TM, Kelley KA, Ranges GE, Bombara MP. Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J Immunol 1990; 145: 1826-31.
43. Silverman DHS, Hong W, Kamovsky ML. Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release. Biochem Biophys Res Com 1985; 131: 1160-67.
44. Cloëz-Tayarani I, Cardona A, Havet N, Edelman L, Touqui L. Serotonin binds to specific sites on alveolar macrophages and increases lipid peroxidation. J Leuk Biol Suppl 2000; 29: 29.
45. Stefulj J, Jernej B, Cicin-Sain L, Rinner I; Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun 2000; 14: 219-24.
46. 1A receptor mRNA and protein in activated B and T lymphocytes. J Biol Chem 2001; 276: 4382-8.
47. Cloëz-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM. Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-Hydroxytryptamine2A receptors. Int Immunol 2003; 15: 233-40.
48. Aune TM, McGrath KM, Sarr T, Bombara MP, Kelley KA. Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J Immunol 1993; 151: 1175-83.
49. Khan NA, Poisson JP. 5-HT3 receptor-channels coupled with Na+ influx in human T cells: role in T cell activation. J Neuroimmunol 1999; 99: 53-60.
50. 1A receptors. Life Sci 2004; 76: 429-43.
51. Meyniel JP, Khan NA, Ferriere F, Deschaux P. Identification of lymphocyte 5-HT3 receptor subtype and its implication in fish T-cell proliferation. Immunol Lett 1997; 55: 151-60.
52. Fiebich BL, Akundi RS, Seidel M, et al. Expression of 5-HT3A receptors in cells of the immune system. Scand J Rheumatol Suppl 2004; 119: 9-11.
53. Sternberg EM, Wedner HJ, Leung MK, Parker CW. Effect of serotonin (5-HT) and other monoamines on murine macrophages: modulation of interferon-γ induced phagocytosis. J Immunol 1987; 138: 4360-5.
54. Hsueh CM, Chen SF, Lin RJ, Chao HJ. Cholinergic and serotonergic activities are required in triggering conditioned NK cell response. J Neuroimmunol 2002; 123: 102-11.
55. Hellstrand K, Herdmodsson H. Monocyte-mediated suppression of IL2-induced NK-cell activation. Scand J Immunol 1990; 32: 183-92.
56. Hellstrand K, Kylefjord H, Asea A, Hermodsson S. Regulation of the natural killer cell response to interferon-α by biogenic amines. J Interferon Res 1992; 12: 199-206.
57. Betten A, Dahlgren C, Mellqvist UH, Hermodsson S, Hellstrand K. Oxygen radical-induced natural killer cell dysfunction: role of myeloperoxidase and regulation by serotonin. J Leukoc Biol 2004; 75: 1111-5.
58. Hellstrand K, Czerkinsky C, Ricksten A, et al. Role of serotonin in the regulation of interferon-γ production by human natural killer cells. J Interferon Res 1993; 13: 33-8.
59. Frank MG, Johnson DR, Hendricks SE, Frank JL. Monocyte 5-HT1A receptors mediate pindobind suppression of natural killer cell activity: modulation by catalase. Int Immunopharmacol 2001; 1: 247-53.
60. Kubera M, Kenis G, Bosmans E, Scharpe S, Maes M., Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10. Neuropsychopharmacology 2000; 23: 89-98.
61. Foon KA, Wahl SM, Oppenheim JJ, Rosenstreich DL. Serotonin-induced production of a monocyte chemotactic factor by human peripheral blood leukocytes. J Immunol 1976; 117: 1545-52.
62. Laberge S, Cruikshank WW, Beer DJ, Center DM. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol 1996; 156: 310-5.
63. Idzko M, Panther E, Stratz C, et al. The serotonergic receptors of human dendritic cells: Identification and coupling to cytokine release. J Immunol 2004; 172: 6011-19.
64. Victor VM, De la Fuente M. Several functions of immune cells in mice changed by oxidative stress caused by endotoxin. Physiol Res 2003; 52: 789-96.
65. Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95: 930-5.
66. Shi MM, Godleski JJ, Paulauskis JD. Regulation of macrophage inflammatory protein-lalpha mRNA by oxidative stress. J Biol Chem 1996; 271: 5878-83.
67. Shi MM, Chong I, Godleski JJ, Paulauskis JD. Regulation of macrophage inflammatory protein-2 gene expression by oxidative stress in rat alveolar macrophages. Immunology 1999; 97: 309-15.
68. Driscoll KE. TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicol Lett 2000; 112-113: 177-83.
69. Trinchieri G, Kubin M, Bellone G, Cassatella MA. Cytokine crosstalk between phagocytic cells and lymphocytes: relevance for differentiation/ activation of phagocytic cells and regulation of adaptive immunity. J Cell Biochem 1993; 53: 301-8.
70. Young MR, Kut JL, Coogan MP, Wright MA, Young ME, Matthews J. Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology 1993; 80: 395-400.
71. Aune TM, Golden HW, McGrath KM. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J Immunol 1994; 153:489-98.
72. Clancy J Jr, Petrovic LM, Gordon BH, Handa RJ, Campbell DB, Lorens SA. Effects of subchronic d-fenfluramine on splenic immune functions in young and old male and female Fischer 344 rats. Int J Immunopharmacol 1991: 1203-12.
73. Pellegrino TC, Bayer BM. Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity. Brain Behav Immun 2002; 16: 87-103.
74. Ferriere F, Khan NA, Troutaud D, Deschaux P. Serotonin modulation of lymphocyte proliferation via 5-HT1A receptors in rainbow trout (Oncorhynchus mykiss). Dev Comp Immunol 1996; 20: 273-83.
75. Raymond JR, Mukhin YV, Gelasko A. Multiplicity of mechanisms of receptor signal transduction. Pharmacol Therapeut 2001; 92: 179-212.
76. Iken K, Chheng S, Fargin A, Goulet AC, Kouassi E. Serotonin upregulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors. Cell Immunol. 1995; 1631:1-9.
77. Bonnet M, Lespinats G, Burtin C. Histamine and serotonin suppression of lymphocyte response to phytohemagglutinin and allogeneic cells. Cell Immunol 1984; 83: 280-91.
78. Khan IA, Bhardwaj G, Malla N, Wattal C, Agarwal SC. Effect of serotonin on T lymphocyte proliferation in vitro in healthy individuals. Int Arch Allergy Appl Immunol 1986; 81: 378-380.
79. Kut JL, Young MRI, Crayton JW, Wright MA, Young ME. Regulation of murine T-lymphocyte function by spleen cell-derived and exogenous serotonin. Immunopharmacol Immunotoxicol 1992; 14: 783-796.
80. Stefulj J, Jakopec S, Osmak M, Jernej B. Serotonin and apoptosis: studies on rat lymphocytes. Neuroimmunomodulation 2002-2003; 10: 132-3.
81. 1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-kappaB to the nucleus. Brain Behav Immun 2004; 18: 24-34.
82. Cowen DS, Molinoff PB, Manning DR. 5-Hydroxytryptamine1A receptor-mediated increase in receptor expression and activation of nuclear factor-κ B in transfected Chinese hamster ovary cells. Mol Pharmacol 1997; 52: 221-226.
83. Liu JP, Lauder JM. Serotonin and nialamide differentially regulate survival and growth of cultured serotonin and catecholamine neurons. Brain Res Dev Brain Res 1991; 62: 297-305.
84. Adayev T, El-Sherif Y, Barua M, Penington NJ, Banerjee P. Agonist stimulation of the serotonin1A receptor causes suppression of anoxia-induced apoptosis via mitogen-activated protein kinase in neuronal HN2-5 cells. J Neurochem 1999; 72: 1489-96.
85. Persico AM, Baldi A, Dell'Acqua ML, et al. Reduced programmed cell death in brains of serotonin transporter knockout mice. Neuroreport 2003; 14(3): 341-4.
86. Meredith EJ, Holder MJ, Chamba A, et al. The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential antitumor target for psychotropics. FASEB J 2005; 19: 1187-9.
87. 1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-kappaB to the nucleus. Brain Behav Immun 2004; 18: 24-34.
88. Mukhin YV, Garnovskaya. MN, Collinsworth G, et al. 5-Hydroxytryptamine 1 A receptor/Gibetagamma stimulates mitogen-activated protein kinase via NAD(P)H oxidase and reactive oxygen species upstream of src in chinese hamster ovary fibroblasts. Biochem J 2000; 347: 61-7.
89. Dent P, Yacoub A, Comtessa J, Caron R, et al. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiation Res 2003; 159: 283-300.
90. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9: 726-35.
91. Kurrash-Orbaugh DM, Parrish JC, Watts VJ, Nichols DE. A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases. J Neurochem 2003; 86: 980-91.
92. Fanburg BL, Lee SL. A new role for an old molecule: serotonin as a mitogen. Am J Physiol (Lung Cell Mol Physiol) 1997; 272: L795-806.
93. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000; 279(6): L1005-28.
94. Thannickal VJ. The paradox of reactive oxygen species: injury, signaling, or both? Am J Physiol Lung Cell Mol Physiol 2003; 284: L24-5.
95. 1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. J Biol Chem 1999; 274: 4749-53.
96. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-85.
97. 2A receptor signal transduction. J Pharmacol Exp Ther 1998; 284: 346-55.
98. 2A receptor induces TGF-β1 expression in mesengial cells via ERK: proliferative and fibrotic signals. Am J Physiol Renal Physiol 1999; 276: F922-30.
99. Takuwa N, Ganz M, Takuwa Y, Sterzel RB, Rasmussen H. Studies on the mitogenic effects of serotonin in rat mesangial cells. Am J Physiol 1989; 257: F431-9.
100. 2A receptors during endocytosis. J Biol Chem 2000; 276: 8269-77.
101. 2A receptor Coupled to the Jak/ STAT pathway. J Biol Chem 1997; 272:14825-9.